Literature DB >> 8031910

Low and stable prevalence of HIV among drug injectors in Glasgow.

A Taylor1, M Frischer, S T Green, D Goldberg, N McKeganey, L Gruer.   

Abstract

The first HIV-positive diagnosis among injecting drug users (IDU) in Glasgow was made in 1985. By the end of 1987 prevalence among IDU receiving voluntary attributable tests was 4.8%. Since 1990, an annual cross-sectional survey of HIV prevalence and risk behaviours among 500 current Glasgow IDU has provided a more representative sample. Anonymously-tested saliva samples obtained from respondents revealed prevalence rates of 1.8%, 1.2% and 1.0% in 1990, 1991 and 1992 respectively. Since 1987 a wide range of measures aimed at reducing HIV-related risk behaviour among IDU has been introduced and maintained in Glasgow. Against this background, there is evidence that IDU in the city have reduced their risk behaviours. The findings reported here suggest that implementing harm-reduction measures when prevalence is low may inhibit the rapid dissemination of HIV.

Mesh:

Year:  1994        PMID: 8031910     DOI: 10.1177/095646249400500205

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  5 in total

1.  HIV infection among family planning clinic attenders in Glasgow: why prevalence has remained low in this general population group.

Authors:  D Goldberg; S Carr; S Cameron; G Codere
Journal:  Sex Transm Infect       Date:  1998-02       Impact factor: 3.519

2.  Outbreak of HIV infection in a Scottish prison.

Authors:  A Taylor; D Goldberg; J Emslie; J Wrench; L Gruer; S Cameron; J Black; B Davis; J McGregor; E Follett
Journal:  BMJ       Date:  1995-02-04

3.  Viral subtype and heterosexual acquisition of HIV infections diagnosed in Scotland.

Authors:  D L Yirrell; D J Goldberg; J Whitelaw; C McSharry; F Raeside; G Codere
Journal:  Sex Transm Infect       Date:  1999-12       Impact factor: 3.519

4.  Unlinked anonymous HIV study of hospital patients and general practice attenders in Glasgow, 1991-1997.

Authors:  J Johnston; S Cameron; M Stewart; D Goldberg; C Fletcher; W Smyth; G Codere
Journal:  J Clin Pathol       Date:  2000-02       Impact factor: 3.411

5.  Hepatitis C prevalence in injecting drug users in Europe, 1990-2007: impact of study recruitment setting.

Authors:  M Rondy; L Wiessing; S J Hutchinson; C Matheï; F Mathis; V Mravcik; L Norden; M Rosińska; O Scutelniciuc; B Suligoi; F Vallejo; M VAN Veen; M Kretzschmar
Journal:  Epidemiol Infect       Date:  2012-05-17       Impact factor: 4.434

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.